Global Regulatory Topics in Orally-Inhaled and Nasal Drug Product (OINDP) Development
IPAC-RS speakers will address current key issues and industry’s positions regarding the 2018 US FDA draft guidance for MDIs and DPIs, the European Medical Device Regulations, and pharmacopeial updates.
Wednesday 12th December 08:00 – 12:00
Edinburgh International Conference Centre
You can view the Programme here
Membership, structure, strategic priorities, overview of workstreams, accomplishments and impact
Cascade Impaction testing and data analysis, regulatory and pharmaceutical developments
Membership, structure, strategic priorities, overview of workstreams, accomplishments and impact